Atossa Genetics to Present at Two Upcoming Investor Conferences
(firmenpresse) - SEATTLE, WA -- (Marketwired) -- 06/26/13 -- (NASDAQ: ATOS), the Breast Health Company™, today announced that Kyle Guse, CFO and General Counsel, will be presenting at two upcoming investor conferences: the JMP Securities Healthcare Conference in New York City and the Life Science Innovation Northwest 2013 Conference in Seattle.
The JMP Securities Healthcare Conference presentation will take place on Tuesday, July 9, 2013, at 2:00 pm Eastern Time at the St. Regis Hotel. The Life Science Innovation Northwest 2013 Conference presentation will take place on Wednesday, July 10, 2013, at 10:45 am Pacific Time at the Washington State Convention Center.
Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, based in Seattle, WA, is focused on preventing breast cancer through the commercialization of patented, FDA-designated Class II diagnostic medical devices and patented, laboratory developed tests, including its ForeCYTE Breast Health Test which can detect precursors to breast cancer up to eight years before mammography.
The National Reference Laboratory for Breast Health (NRLBH), a wholly owned subsidiary of Atossa Genetics, Inc., is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, Washington.
For additional information on Atossa and its medical devices, please visit . For additional information on the ForeCYTE test and the National Reference Laboratory for Breast Health, please visit .
Atossa Genetics, Inc.
Kyle Guse
Chief Financial Officer and General Counsel
800-351-3902
Matthew D. Haines (Investors)
Managing Director
MBS Value Partners
212-710-9686
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.06.2013 - 12:30 Uhr
Sprache: Deutsch
News-ID 273404
Anzahl Zeichen: 0
contact information:
Town:
SEATTLE, WA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 300 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Atossa Genetics to Present at Two Upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
Atossa Genetics, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
